Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells

FEBS Letters

Volumn 581, Issue 3, 2007, Pages 427-432

  Yotsui, Takamori ^a   Yasuda, Osamu ^a   Kawamoto, Hidenobu ^a   Higuchi, Masayoshi ^a   Chihara, Yukana ^a   Umemoto, Eiji ^a   Tanaka, Toshiyuki ^a   Miyasaka, Masayuki ^a   Rakugi, Hiromi ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti inflammatory activity; Aspirin; Atherosclerosis; ICAM 1; VCAM 1

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOBLAST; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE;

ANTIBODIES, MONOCLONAL; ASPIRIN; ATHEROSCLEROSIS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; JURKAT CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; T-LYMPHOCYTES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33846408332     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.052     Document Type: Article

References (32)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
2. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) III27-III32
3. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J. Am. Coll. Cardiol. 46 (2005) 937-954
4. Schwartz S.M., deBlois D., and O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77 (1995) 445-465
5. Falk E. Why do plaques rupture?. Circulation 86 (1992) III30-III42
6. Bauriedel G., Hutter R., Welsch U., Bach R., Sievert H., and Luderitz B. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc. Res. 41 (1999) 480-488
7. Dhume A.S., Soundararajan K., Hunter III W.J., and Agrawal D.K. Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann. Vasc. Surg. 17 (2003) 1-8
8. Hansson G.K., Holm J., and Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135 (1989) 169-175
9. Chan W.L., Pejnovic N., Hamilton H., Liew T.V., Popadic D., Poggi A., and Khan S.M. Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells. Circ. Res. 96 (2005) 675-683
10. DeGraba T.J. Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation. Stroke 35 (2004) 2712-2719
11. von der Thusen J.H., Kuiper J., van Berkel T.J., and Biessen E.A. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol. Rev. 55 (2003) 133-166
12. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., and Johnson-Tidey R.R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140 (1992) 665-673
13. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996) 672-682
14. Montgomery K.F., et al. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 88 (1991) 6523-6527
15. Ueda A., et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153 (1994) 2052-2063
16. Sakai A., Kume N., Nishi E., Tanoue K., Miyasaka M., and Kita T. P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 310-316
17. (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71-86.
18. Pierce J.W., Read M.A., Ding H., Luscinskas F.W., and Collins T. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156 (1996) 3961-3969
19. Gerli R., Gresele P., Bistoni O., Paolucci C., Lanfrancone L., Fiorucci S., Muscat C., and Costantini V. Salicylates inhibit T cell adhesion on endothelium under nonstatic conditions: induction of L-selectin shedding by a tyrosine kinase-dependent mechanism. J. Immunol. 166 (2001) 832-840
20. Fujimoto T., Kawashima H., Tanaka T., Hirose M., Toyama-Sorimachi N., Matsuzawa Y., and Miyasaka M. CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int. Immunol. 13 (2001) 359-366
21. Toyama-Sorimachi N., Sorimachi H., Tobita Y., Kitamura F., Yagita H., Suzuki K., and Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J. Biol. Chem. 270 (1995) 7437-7444
22. Stemme S., Patarroyo M., and Hansson G.K. Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by beta 1- and beta 2-integrins. Scand. J. Immunol. 36 (1992) 233-242
23. Solem J., Levin M., Karlsson T., Grip L., Albertsson P., and Wiklund O. Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment. J. Intern. Med. 259 (2006) 267-275
24. Libby P., and Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8 (2002) 1257-1262
25. Beg A.A., Finco T.S., Nantermet P.V., and Baldwin Jr. A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell Biol. 13 (1993) 3301-3310
26. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365 (1993) 182-185
27. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
28. Wang X., Feuerstein G.Z., Gu J.L., Lysko P.G., and Yue T.L. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 115 (1995) 89-98
29. Weber C., Erl W., Pietsch A., and Weber P.C. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91 (1995) 1914-1917
30. Golledge J., Greenhalgh R.M., and Davies A.H. The symptomatic carotid plaque. Stroke 31 (2000) 774-781
31. Needs C.J., and Brooks P.M. Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinet. 10 (1985) 164-177
32. Higgs G.A., Salmon J.A., Henderson B., and Vane J.R. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc. Natl. Acad. Sci. USA 84 (1987) 1417-1420